TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
FOXA2 |
endometrium |
Phase: MS (mid-secretory) |
Permissive
|
Homo sapiens |
GSE121586
...
|
MA0047.3
|
FOXA2 |
HepG2 (hepatoblastoma) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
HepG2 (hepatoblastoma) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
KerCT (keratenocytes) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
KerCT (keratenocytes) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
KerCT (keratenocytes) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
definitive endoderm(dEN, ES derived) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
definitive endoderm(dEN, ES derived) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: cTermCDT1 |
Permissive
Robust
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
FOXA2 |
BJ (fibroblasts) |
Treatment: to induce FOXA2, doxycycline was added at 5ug/mL Genotype: wildtype FOCA2 |
Permissive
|
Homo sapiens |
GSE90454
...
|
MA0047.3
|
Showing 10 records in page 361
from 963 pages